{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:26:07Z","timestamp":1791257167237,"version":"4.1.0"},"reference-count":35,"publisher":"Portland Press Ltd.","issue":"10","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,11,1]]},"abstract":"<jats:p>Increased systemic and pulmonary levels of IL-6 (interleukin-6) are associated with the severity of exacerbations and decline of lung function in patients with COPD (chronic obstructive pulmonary disease). Whether IL-6 is directly involved or plays a bystander role in the pathophysiology of COPD remains unclear. Here we hypothesized that neutralizing circulating levels of IL-6 would modulate episodes of acute pulmonary inflammation following CS (cigarette smoke) exposure and virus-like challenges. For this purpose, we used a model where C57BL\/6 mice were exposed to CS twice daily via a nose-only system, and concomitant periodic intranasal challenge with poly(I:C), a synthetic ligand for TLR3 (Toll-like receptor 3) that mimics the encounter with double stranded RNA that is carried by influenza-like viruses. This protocol recapitulates several aspects of acute pulmonary inflammation associated with COPD, including prominent airway neutrophilia, insensitivity to steroid treatment and increased levels of several inflammatory cytokines in BAL (bronchoalveolar lavage) samples. Although IL-6-deficient mice exposed to CS\/poly(I:C) developed pulmonary inflammation similar to WT (wild-type) controls, WT mice exposed to CS\/poly(I:C) and treated intraperitoneally with IL-6-neutralizing antibodies showed significantly lower blood counts of lymphocytes and monocytes, lower BAL levels of IL-6 and CXCL1 (CXC chemokine ligand 1)\/KC (keratinocyte chemoattractant), as well as reduced numbers of BAL neutrophils, lymphocytes and macrophages. Our results thus indicate that the systemic neutralization of IL-6 significantly reduces CS\/poly(I:C)-induced pulmonary inflammation, which may be a relevant approach to the treatment of episodes of acute pulmonary inflammation associated with COPD.<\/jats:p>","DOI":"10.1042\/cs20130110","type":"journal-article","created":{"date-parts":[[2013,6,7]],"date-time":"2013-06-07T08:39:16Z","timestamp":1370594356000},"page":"483-493","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Interleukin-6 neutralization alleviates pulmonary inflammation in mice exposed to cigarette smoke and poly(I:C)"],"prefix":"10.1042","volume":"125","author":[{"given":"Cedric","family":"Hubeau","sequence":"first","affiliation":[{"name":"Inflammation and Remodeling Research Unit, Pfizer Worldwide Research and Development, 200 Cambridgepark Drive, Cambridge, MA 02140, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John\u00a0E.","family":"Kubera","sequence":"additional","affiliation":[{"name":"Inflammation and Remodeling Research Unit, Pfizer Worldwide Research and Development, 200 Cambridgepark Drive, Cambridge, MA 02140, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Masek-Hammerman","sequence":"additional","affiliation":[{"name":"Drug Safety Research and Development, Pfizer Worldwide Research and Development, 200 Cambridgepark Drive, Cambridge, MA 02140, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara\u00a0M. M.","family":"Williams","sequence":"additional","affiliation":[{"name":"Inflammation and Remodeling Research Unit, Pfizer Worldwide Research and Development, 200 Cambridgepark Drive, Cambridge, MA 02140, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2013,7,16]]},"reference":[{"key":"2021113010245401400_B1","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1164\/rccm.200703-456SO","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary","volume":"176","author":"Rabe","year":"2007","journal-title":"Am. J. Respir. Crit. Care. Med."},{"key":"2021113010245401400_B2","doi-asserted-by":"crossref","first-page":"2445","DOI":"10.1056\/NEJMra0804752","article-title":"Immunologic aspects of chronic obstructive pulmonary disease","volume":"360","author":"Cosio","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"2021113010245401400_B3","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1183\/09031936.00109906","article-title":"Exacerbations of chronic obstructive pulmonary disease","volume":"29","author":"Celli","year":"2007","journal-title":"Eur. Respir. J."},{"key":"2021113010245401400_B4","doi-asserted-by":"crossref","first-page":"e37483","DOI":"10.1371\/journal.pone.0037483","article-title":"Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype","volume":"7","author":"Agusti","year":"2012","journal-title":"PLoS ONE"},{"key":"2021113010245401400_B5","doi-asserted-by":"crossref","first-page":"e46207","DOI":"10.1371\/journal.pone.0046207","article-title":"Repeatability of and relationship between potential COPD biomarkers in bronchoalveolar lavage, bronchial biopsies, serum, and induced sputum","volume":"7","author":"Ropcke","year":"2012","journal-title":"PLoS ONE"},{"key":"2021113010245401400_B6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1164\/rccm.200505-704OC","article-title":"Systemic and upper and lower airway inflammation at exacerbation of chronic obstructive pulmonary disease","volume":"173","author":"Hurst","year":"2006","journal-title":"Am. J. Respir. Crit. Care. Med."},{"key":"2021113010245401400_B7","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1378\/chest.128.4.1995","article-title":"Airway and systemic inflammation and decline in lung function in patients with COPD","volume":"128","author":"Donaldson","year":"2005","journal-title":"Chest"},{"key":"2021113010245401400_B8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1378\/chest.06-0668","article-title":"Systemic cytokines, clinical and physiological changes in patients hospitalized for exacerbation of COPD","volume":"131","author":"Pinto-Plata","year":"2007","journal-title":"Chest"},{"key":"2021113010245401400_B9","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1378\/chest.08-2420","article-title":"Role for interleukin-6\u00a0in COPD-related pulmonary hypertension","volume":"136","author":"Chaouat","year":"2009","journal-title":"Chest"},{"key":"2021113010245401400_B10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s12016-011-8265-z","article-title":"The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension","volume":"44","author":"Kherbeck","year":"2011","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"2021113010245401400_B11","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/thx.2008.111278","article-title":"Associations of IL6 polymorphisms with lung function decline and COPD","volume":"64","author":"He","year":"2009","journal-title":"Thorax"},{"key":"2021113010245401400_B12","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1002\/emmm.201100627","article-title":"Emerging genetics of COPD","volume":"4","author":"Berndt","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"2021113010245401400_B13","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1378\/chest.07-2085","article-title":"Interleukin-6: a red herring or a real catch in COPD?","volume":"133","author":"Sin","year":"2008","journal-title":"Chest"},{"key":"2021113010245401400_B14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3109\/01902141003739723","article-title":"The role of interleukin-6\u00a0in pulmonary and systemic manifestations in a murine model of chronic obstructive pulmonary disease","volume":"36","author":"Pauwels","year":"2010","journal-title":"Exp. Lung Res."},{"key":"2021113010245401400_B15","first-page":"2771","article-title":"Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice","volume":"118","author":"Kang","year":"2008","journal-title":"J. Clin. Invest."},{"key":"2021113010245401400_B16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1476-9255-6-10","article-title":"Evaluation of anti-IL-6 monoclonal antibody therapy using murine type\u00a0II collagen-induced arthritis","volume":"6","author":"Liang","year":"2009","journal-title":"J. Inflamm."},{"key":"2021113010245401400_B17","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1513\/pats.200903-012DS","article-title":"Testing drugs in animal models of cigarette smoke-induced chronic obstructive pulmonary disease","volume":"6","author":"Churg","year":"2009","journal-title":"Proc. Am. Thorac. Soc."},{"key":"2021113010245401400_B18","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/j.bbamcr.2011.01.034","article-title":"The pro- and anti-inflammatory properties of the cytokine interleukin-6","volume":"1813","author":"Scheller","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"2021113010245401400_B19","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1513\/pats.200802-014ET","article-title":"New concepts in the pathobiology of chronic obstructive pulmonary disease","volume":"5","author":"Kim","year":"2008","journal-title":"Proc. Am. Thorac. Soc."},{"key":"2021113010245401400_B20","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1165\/rcmb.2011-0087PS","article-title":"Everything prevents emphysema: are animal models of cigarette smoke-induced chronic obstructive pulmonary disease any use?","volume":"45","author":"Churg","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2021113010245401400_B21","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.jaci.2012.12.1564","article-title":"Corticosteroid resistance in patients with asthma and chronic obstructive pulmonary disease","volume":"131","author":"Barnes","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"key":"2021113010245401400_B22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1164\/rccm.200912-1794OC","article-title":"Neutralizing granulocyte\/macrophage colony-stimulating factor inhibits cigarette smoke-induced lung inflammation","volume":"182","author":"Vlahos","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2021113010245401400_B23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1183\/09031936.00076210","article-title":"A mouse GM-CSF receptor antibody attenuates neutrophilia in mice exposed to cigarette smoke","volume":"38","author":"Botelho","year":"2011","journal-title":"Eur. Respir. J."},{"key":"2021113010245401400_B24","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1164\/rccm.200204-298OC","article-title":"Impaired inhibition by dexamethasone of cytokine release by alveolar macrophages from patients with chronic obstructive pulmonary disease","volume":"167","author":"Culpitt","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2021113010245401400_B25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1742-7843.2011.00707.x","article-title":"Resveratrol impairs the release of steroid-resistant cytokines from bacterial endotoxin-exposed alveolar macrophages in chronic obstructive pulmonary disease","volume":"109","author":"Knobloch","year":"2011","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"2021113010245401400_B26","doi-asserted-by":"crossref","first-page":"L627","DOI":"10.1152\/ajplung.00285.2011","article-title":"Deregulated Stat3 signaling dissociates pulmonary inflammation from emphysema in gp130 mutant mice","volume":"302","author":"Ruwanpura","year":"2012","journal-title":"Am. J. Physiol. Lung. Cell Mol. Physiol."},{"key":"2021113010245401400_B27","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.4049\/jimmunol.1003221","article-title":"CX3CR1+ lung mononuclear phagocytes spatially confined to the interstitium produce TNF-\u03b1 and IL-6 and promote cigarette smoke-induced emphysema","volume":"186","author":"Xiong","year":"2011","journal-title":"J. Immunol."},{"key":"2021113010245401400_B28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1165\/ajrcmb.22.3.3690","article-title":"Airway hyperresponsiveness and airway obstruction in transgenic mice. Morphologic correlates in mice overexpressing interleukin (IL)-11 and IL-6\u00a0in the lung","volume":"22","author":"Kuhn","year":"2000","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2021113010245401400_B29","doi-asserted-by":"crossref","first-page":"17036","DOI":"10.1074\/jbc.M210429200","article-title":"Stimulation of airway mucin gene expression by interleukin (IL)-17 through IL-6 paracrine\/autocrine loop","volume":"278","author":"Chen","year":"2003","journal-title":"J. Biol. Chem."},{"key":"2021113010245401400_B30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1183\/09031936.00.15110900","article-title":"Comparison of induced sputum with bronchial wash, bronchoalveolar lavage and bronchial biopsies in COPD","volume":"15","author":"Rutgers","year":"2000","journal-title":"Eur. Respir. J."},{"key":"2021113010245401400_B31","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1159\/000114855","article-title":"Decreased cytokine and chemokine mRNA expression in bronchoalveolar lavage in asymptomatic smoking subjects","volume":"75","author":"Meuronen","year":"2008","journal-title":"Respiration"},{"key":"2021113010245401400_B32","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nri2254","article-title":"Immunology of asthma and chronic obstructive pulmonary disease","volume":"8","author":"Barnes","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"2021113010245401400_B33","first-page":"3833","article-title":"TNF-\u03b1 is critical for antitumor but not antiviral T cell immunity in mice","volume":"117","author":"Calzascia","year":"2007","journal-title":"J. Clin. Invest."},{"key":"2021113010245401400_B34","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1158\/1940-6207.CAPR-10-0180","article-title":"Interleukin 6, but not T helper 2 cytokines, promotes lung carcinogenesis","volume":"4","author":"Ochoa","year":"2011","journal-title":"Cancer Prev. Res."},{"key":"2021113010245401400_B35","doi-asserted-by":"crossref","first-page":"15535","DOI":"10.1073\/pnas.1009472107","article-title":"TGF-\u03b2 IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer","volume":"107","author":"Yao","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/125\/10\/483\/443510\/cs1250483.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/125\/10\/483\/443510\/cs1250483.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T10:55:23Z","timestamp":1638269723000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/125\/10\/483\/69063\/Interleukin-6-neutralization-alleviates-pulmonary"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,16]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,11,1]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20130110","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,16]]}}}